Analyst Rating Changes — Upgrades, Downgrades & Price Targets

33529 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Price-Target Changes

WhenStockChange FirmAnalyst RatingPrice Target
Oct 13
00:11 UTC
MIRM
Mirum Pharmaceuticals
◎ Target Citigroup Yigal Nochomovitz ★★☆☆☆ #2785 Buy $160.00→ $184.00+15.0%
Oct 13
00:11 UTC
MGM
MGM Resorts International
◎ Target Citigroup James Hardiman ★★☆☆☆ #2771 Neutral $48.00→ $32.00-33.3%
Oct 13
00:11 UTC
MGA
Magna International
◎ Target Royal Bank Of Canada Tom Narayan ★★★☆☆ #1639 Sec→ r Perform $69.00→ $68.00-1.4%
Oct 13
00:11 UTC
META
Meta Platforms
◎ Target Cantor Fitzgerald Deepak Mathivanan ★★★☆☆ #1948 Overweight $860.00→ $840.00-2.3%
Oct 13
00:11 UTC
MET
MetLife
◎ Target Wells Fargo & Company Wesley Carmichael ★★★★☆ #858 Overweight $109.00→ $110.00+0.9%
Oct 13
00:11 UTC
MELI
MercadoLibre
◎ Target Cantor Fitzgerald Deepak Mathivanan ★★★☆☆ #1948 Overweight $2,300.00→ $2,200.00-4.3%
Oct 13
00:11 UTC
MDT
Medtronic
◎ Target BTIG Research Ryan Zimmerman ★★☆☆☆ #2482 Buy $100.00→ $99.00-1.0%
Oct 13
00:11 UTC
MBX
MBX Biosciences
◎ Target Stifel Nicolaus Annabel Samimy ★☆☆☆☆ #3079 Buy $70.00→ $84.00+20.0%
Oct 13
00:11 UTC
MAR
Marriott International
◎ Target Morgan Stanley Stephen Grambling ★★★☆☆ #1657 Overweight $380.00→ $384.00+1.1%
Oct 13
00:11 UTC
MAIR
Madison Air Solutions
◎ Target Citigroup Andrew Kaplowitz ★★★☆☆ #2164 Buy $49.00→ $40.00-18.4%
Oct 13
00:11 UTC
MAC
Macerich
◎ Target Piper Sandler Alexander Goldfarb ★★★☆☆ #1807 Overweight $30.00→ $26.00-13.3%
Oct 13
00:11 UTC
MAA
Mid-America Apartment Communities
◎ Target Piper Sandler Alexander Goldfarb ★★★☆☆ #1807 Neutral $140.00→ $121.00-13.6%
Oct 13
00:11 UTC
LPX
Louisiana-Pacific
◎ Target The Goldman Sachs Group Susan Maklari ★★★☆☆ #1961 Sell $74.00→ $64.00-13.5%
Oct 13
00:11 UTC
LPLA
LPL Financial
◎ Target TD Cowen Bill Katz not yet tracked Hold $377.00→ $380.00+0.8%
Oct 13
00:11 UTC
LNC
Lincoln National
◎ Target Wells Fargo & Company Wesley Carmichael ★★★★☆ #858 Overweight $52.00→ $54.00+3.8%
Oct 13
00:11 UTC
LINE
Lineage
◎ Target Piper Sandler Alexander Goldfarb ★★★☆☆ #1807 Neutral $44.00→ $36.00-18.2%
Oct 13
00:11 UTC
LIFE
Ethos Technologies Inc. Class A Common Stock
◎ Target Citizens Jmp Matthew Carletti ★★★☆☆ #1122 Market Outperform $33.00→ $40.00+21.2%
Oct 13
00:11 UTC
LHX
L3Harris Technologies
◎ Target The Goldman Sachs Group Noah Poponak ★☆☆☆☆ #2955 Buy $405.00→ $361.00-10.9%
Oct 13
00:11 UTC
LEA
Lear
◎ Target Royal Bank Of Canada Tom Narayan ★★★☆☆ #1639 Sec→ r Perform $143.00→ $139.00-2.8%
Oct 13
00:11 UTC
LCID
Lucid Group
◎ Target Royal Bank Of Canada Tom Narayan ★★★☆☆ #1639 Sec→ r Perform $7.00→ $4.00-42.9%
Oct 13
00:11 UTC
KTOS
Kratos Defense & Security Solutions
◎ Target The Goldman Sachs Group Noah Poponak ★☆☆☆☆ #2955 Buy $88.00→ $77.00-12.5%
Oct 13
00:11 UTC
KOD
Kodiak Sciences
◎ Target HC Wainwright Matthew Caufield ★★☆☆☆ #2492 Buy $96.00→ $126.00+31.2%
Oct 13
00:11 UTC
KNSL
Kinsale Capital Group
◎ Target Wells Fargo & Company Hristian Getsov ★★★★☆ #612 Equal Weight $377.00→ $348.00-7.7%
Oct 13
00:11 UTC
KKR
KKR & Co. Inc.
◎ Target TD Cowen Bill Katz not yet tracked Hold $118.00→ $103.00-12.7%
Oct 13
00:11 UTC
KIM
Kimco Realty
◎ Target Piper Sandler Alexander Goldfarb ★★★☆☆ #1807 Overweight $31.00→ $27.00-12.9%
Oct 13
00:11 UTC
JSG
Johnson Service Group
◎ Target Deutsche Bank Aktiengesellschaft firm only Buy GBX 210→ GBX 200-4.8%
Oct 13
00:11 UTC
JCI
Johnson Controls International
◎ Target Citigroup Andrew Kaplowitz ★★★☆☆ #2164 Neutral $157.00→ $170.00+8.3%
Oct 13
00:11 UTC
IVZ
Invesco
◎ Target TD Cowen Bill Katz not yet tracked Buy $39.00→ $38.00-2.6%
Oct 13
00:11 UTC
ISRG
Intuitive Surgical
◎ Target BTIG Research Ryan Zimmerman ★★☆☆☆ #2482 Buy $469.00→ $454.00-3.2%
Oct 13
00:11 UTC
IP
International Paper
◎ Target Truist Financial Michael Roxland ★★★☆☆ #1230 Buy $49.00→ $41.00-16.3%
Oct 13
00:11 UTC
INVH
Invitation Home
◎ Target UBS Group Michael Goldsmith ★★★☆☆ #2233 Buy $35.00→ $31.00-11.4%
Oct 13
00:11 UTC
INTA
Intapp
◎ Target Barclays Saket Kalia ★★★★★ #124 Underweight $29.00→ $38.00+31.0%
Oct 13
00:11 UTC
INIO
Innio
◎ Target Citigroup Andrew Kaplowitz ★★★☆☆ #2164 Neutral $30.00→ $22.00-26.7%
Oct 13
00:11 UTC
IIPR
Innovative Industrial Properties
◎ Target Piper Sandler Alexander Goldfarb ★★★☆☆ #1807 Underweight $51.00→ $44.00-13.7%
Oct 13
00:11 UTC
ICG
Intermediate Capital Group
◎ Target Jefferies Financial Group firm only Buy GBX 2,800→ GBX 2,700-3.6%
Oct 13
00:11 UTC
ICE
Intercontinental Exchange
◎ Target TD Cowen Bill Katz not yet tracked Hold $166.00→ $167.00+0.6%
Oct 13
00:11 UTC
IBP
Installed Building Products
◎ Target The Goldman Sachs Group Susan Maklari ★★★☆☆ #1961 Buy $297.00→ $257.00-13.5%
Oct 13
00:11 UTC
HUM
Humana
◎ Target Oppenheimer Michael Wiederhorn ★★★★☆ #343 Outperform $475.00→ $525.00+10.5%
Oct 13
00:11 UTC
HUM
Humana
◎ Target UBS Group A.J. Rice ★★★★☆ #702 Neutral $405.00→ $495.00+22.2%
Oct 13
00:11 UTC
HUM
Humana
◎ Target Truist Financial David MacDonald not yet tracked Hold $415.00→ $475.00+14.5%
Oct 13
00:11 UTC
HST
Host Hotels & Resorts
◎ Target Morgan Stanley Stephen Grambling ★★★☆☆ #1657 Equal Weight $22.00→ $24.00+9.1%
Oct 13
00:11 UTC
HRI
Herc
◎ Target Citigroup Kyle Menges ★★☆☆☆ #2356 Buy $175.00→ $150.00-14.3%
Oct 13
00:11 UTC
HP
Helmerich & Payne
◎ Target UBS Group Josh Silverstein ★★★☆☆ #1661 Buy $49.00→ $50.00+2.0%
Oct 13
00:11 UTC
HP
Helmerich & Payne
◎ Target Barclays Eddie Kim ★★★☆☆ #1307 Overweight $50.00→ $51.00+2.0%
Oct 13
00:11 UTC
HON
Honeywell International
◎ Target Citigroup Andrew Kaplowitz ★★★☆☆ #2164 Buy $279.00→ $270.00-3.2%
Oct 13
00:11 UTC
HNGE
Hinge Health
◎ Target Barclays Saket Kalia ★★★★★ #124 Overweight $100.00→ $110.00+10.0%
Oct 13
00:11 UTC
HLT
Hilton Worldwide
◎ Target Morgan Stanley Stephen Grambling ★★★☆☆ #1657 Overweight $332.00→ $336.00+1.2%
Oct 13
00:11 UTC
HIG
The Hartford Insurance Group
◎ Target Wells Fargo & Company Elyse Greenspan ★★★☆☆ #1080 Overweight $164.00→ $158.00-3.7%
Oct 13
00:11 UTC
HIG
The Hartford Insurance Group
◎ Target Keefe, Bruyette & Woods Meyer Shields ★★★★☆ #400 Market Perform $144.00→ $137.00-4.9%
Oct 13
00:11 UTC
HHH
Howard Hughes
◎ Target Piper Sandler Alexander Goldfarb ★★★☆☆ #1807 Overweight $100.00→ $83.00-17.0%
🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.
A free account unlocks the full daily feed.
‹ Prev 24 / 671 Next ›

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.